Search Results - "Dunzendorfer, U"

Clinical experience: symptomatic management of BPH with terazosin by Dunzendorfer, U

“…Several reports in the literature have suggested that alpha-receptor blockade may have therapeutic value in treating the symptoms of patients with benign…”
Get more information

Hormonal chemotherapy by Dunzendorfer, U

Get more information

Change of urinary excretion of electrolytes after acid, base and furosemide application in sponge kidney by Dunzendorfer, U

“…Sponge kidney is rare clinical and pathological entity, incidentally found in 0.4--1% of all excretory urographies. In the advanced stage of the disease,…”
Get more information

The effect of alpha-difluoromethyl-ornithine on tumor growth, acute phase reactants, beta-2-microglobulin and hydroxyproline in kidney and bladder carcinomas by Dunzendorfer, U

“…Multiple oral doses of alpha-difluoromethyl-ornithine (alpha-DFMO), 18-24 g/day for up to 2 months, were administered to 2 patients with invasive and…”
Get more information

Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study by Dunzendorfer, U

“…Several reports in the literature suggest that alpha-receptor blockade may have therapeutic value in treating the symptoms of patients with benign prostatic…”
Get more information

Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients by Dunzendorfer, U, Jurincic, C

“…Patients with testis tumor were investigated for serum and tissue levels of alpha-fetoprotein and beta-human chorionic gonadotropin (beta-HCG). The tissue…”
Get more information

alpha-Difluoromethylornithine (alpha DFMO) and phenoxybenzamine hydrochloride in the treatment of chronic non-suppurative prostatitis by Dunzendorfer, U

“…In a single-blind, placebo-controlled, cross-over study in 11 patients with chronic non-suppurative, culture-negative prostatitis,…”
Get more information

Transferrin, C3 complement, haptoglobin, plasminogen and alpha 2-microglobulin in patients with urogenital tumors by Dunzendorfer, U, Jung, K, Ohlenschläger, G

“…The serum levels of transferrin, haptoglobin, C3 proactivator, plasminogen and alpha 2-macroglobulin have been measured in patients suffering from urogenital…”
Get more information

Testosterone, LH and FSH in patients with treated testicular carcinomas by Dunzendorfer, U, Weber, W

“…Patients with testicular cancer were treated by semicastratio and in some cases by retroperitoneal surgery. The diminution of testicular parenchyma to about…”
Get more information

C-peptide, testosterone, estrogen, cortisol and zinc in patients with benign hyperplasia of the prostate by Dunzendorfer, U, Drahovsky, D

“…Patients with benign hyperplasia of the prostate (BHP) were studied in relation to aberrant serum c-peptide, testosterone, estrone, cortisol and morning…”
Get more information

Cytotoxicity and metabolism of E-DES-diphosphate by Oelschläger, H, Rothley, D, Dunzendorfer, U

Get more information

Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers by Drahovsky, D, Dunzendorfer, U, Ziegenhagen, G, Drahovsky, M, Kellen, J A

“…C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive methods such as radioimmunoassay. Patients with some…”
Get more information

Na-tartrate in the treatment of chronic nonbacterial prostatitis by Dunzendorfer, U, Kruschwitz, K, Feller, H, Milbradt, R

“…In an open investigation 20 patients with a history of chronic abacterial prostatitis (24 month duration) and of multiple therapies were treated by…”
Get more information

Aberrant peptide hormones in patients with urogenital carcinomas by Dunzendorfer, U, Weber, W, Drahovsky, D

“…A series of 229 patients with urogenital carcinomas were investigated for aberrant peptide hormone activities. Serum TSH and prolactin were frequently measured…”
Get more information

Altered polyamines and peptide hormones (FSH, TSH, prolactin, C-peptide) in prostatic hyperplasia and kidney tumors by Dunzendorfer, U, Russell, D H

Get more information

Experimental chemotherapy in a transplantable renal adenocarcinoma. I: Effects of some inhibitors of polyamine synthesis by Dunzendorfer, U, Kleinert, E, Whitmore, Jr, W F

“…Difluoromethylornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG), inhibitors of ornithine decarboxylase (ODC) and S-adenosylmethionine…”
Get more information

Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer by Dunzendorfer, U, Relyea, N M, Kleinert, E, Balis, M E, Whitmore, Jr, W F

“…Inhibitors of polyamine synthesis were tested for therapeutic effectiveness on transplantable prostate cancer. Inhibition of either ornithine decarboxylase or…”
Get more information

Prolactin, LH, TSH, T3 and T4 in patients with urogenital carcinomas by Dunzendorfer, U, Knöner, M, Drahowsky, D

“…Serum level of peptide hormones LH, FSH, TSH and prolactin have been measured in patients with urogenital tumor. In this randomized study we found a frequent…”
Get more information

Synthesis and body distribution of alpha-aminoisobutyric acid-L-11C in normal and prostate cancer-bearing rat after chemotherapy by Dunzendorfer, U, Schmall, B, Bigler, R E, Zanzonico, P B, Conti, P S, Dahl, J R, Kleinert, E, Whitmore, W F

“…This paper describes the synthesis of alpha-aminoisobutyric acid-11C (11C-AIB) and studies its body distribution in healthy and tumor-bearing animals. High…”
Get full text

13,14-Dihydro-15-keto-prostaglandin F2 alpha in patients with urogenital tumors by Dunzendorfer, U, Zahradnik, H P, Gerster, K

“…13,14-Dihydro-15-keto-prostaglandin F2 alpha (13,14-DHK-PGF2 alpha) represents a stable product of degradation after pulmonary flow and it is shown to be…”
Get more information